H2H Featured Question

Home
What is H2H?

H2H Leadership
H2H Steering Committee
H2H Advisory Council
H2H Subgroups

IBT Subgroup
Education Subgroup
Measurement and Evaluation Subgroup
Partnerships Subgroup

H2H Staff
Other Initiatives

Strategic Partnership

National Partners
QIO Partners

Participants
H2H in the News
Enrollment
FAQs
H2H Featured Question
Contact H2H
The H2H Featured Question is a Discussion Board question that is determined to be of particular importance to the H2H community. One of the many experts involved with the H2H Initiative will provide a response to the question or comment. These questions and answers will be updated regularly, so please be sure to check back often!

Note: Please click on the question to see the expert response.

Q1.
Our organization started to use CHF Solutions (Aquapheresis) back in December 2008. To date we have used it on 90+ patients. We are hoping to have an OP component for Aquapheresis & thus decrease unnecessary hospital readmissions. The DOH is currently here at our facility so we should learn this week if we are approved to have the OP offering.

Overall, we are hoping that Aquapheresis therapy can help us cut down on readmissions, and, if initiated early enough in a patient’s hospital stay, perhaps even impact LOS.

That being said, we believe Aquapheresis is only a piece of the complex puzzle in the effort to impact readmissions. We believe the early follow-up appt., f/u phone calls, enhanced communication, collaborative rounds, etc. need to all be in place to drive down readmits.

-Jennifer